Ispire Collaborates with Berify and Chemular on Blockchain Technology

Business by 2FIRSTS.ai

Feb.23.2024

Ispire Collaborates with Berify and Chemular on Blockchain Technology

Ispire collaborates with Touchpoint World Wide Inc. and Chemular International Inc. to accelerate e-cigarette technology innovation in a new venture.

According to a report by UPI on February 22nd, Ispire (ISPIRE) has announced a partnership with Touchpoint World Wide Inc. (Berify, a platform specializing in linking physical products to the digital world, digital engagement, and brand protection) and Chemular International Inc to establish a joint venture.

This joint venture will focus on accelerating innovation in the e-cigarette technology sector, including the development of safe, user-friendly age verification and age restriction vaporized nicotine device solutions.

Inspire Technology Company's Co-CEO Michael Wang stated, "By combining our collective expertise in hardware, blockchain, and regulatory consulting, our goal is to set new standards for age verification, safety, and overall quality in the e-cigarette industry. We hope this joint venture will bring significant advancements in device control, safety, anti-counterfeiting, and enhanced user experience, ultimately improving overall market and consumer satisfaction."

References:

[1] Ispire, Berify and Chemular to Propel Innovation in Vape Hardware Manufacturing Industry

Also Read:

[1] ISPIRE Reports Strong Growth in Q2 FY2024: Operating Expenses Surge to $10.3 Million, Net Loss at $4 Million

[2] Joint Venture Between Ispire and Berify for PMTA and Software Development

#North America #United States #Open system e-cigarettes #Technology.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Altria’s on!PLUS Nicotine Pouches Reportedly Available in U.S.; Users Say They Have Received Orders

Social media users reported purchasing Altria’s new nicotine pouch, on!PLUS, in the United States. 2Firsts found that the official on! website had temporarily opened online purchase and store locator functions. The product has not received FDA authorization. Around the same time, British American Tobacco (BAT) suspended its unlicensed Vuse One vape launch in the U.S. amid regulatory pressure.

Oct.28 by 2FIRSTS.ai

South Korea Again Delays Tobacco Business Act Amendment on Synthetic Nicotine

South Korea’s amendment to the Tobacco Business Act, which would classify synthetic nicotine vapes and vape liquids as “tobacco” for regulatory and taxation purposes, has been delayed once again. Despite the government stressing its urgency due to youth access and risks of illicit drug mixing, both ruling and opposition parties at the Legislation and Judiciary Committee meeting agreed that the bill requires further discussion.

Nov.13 by 2FIRSTS.ai

Imperial Brands Urges Retailers to Engage in Government Consultation on Tobacco and Vapes Bill

Imperial Brands is calling on UK retailers to take part in the Government’s consultation on the Tobacco and Vapes Bill, which will shape a new licensing framework for nicotine product sales across England, Wales and Northern Ireland. The Department of Health and Social Care’s call for evidence closes on 3 December 2025. Imperial Brands stresses this is a key chance for retailers to influence policy, support fair competition, and help curb illicit sales.

Nov.04

Heno Biotech Invited to Speak at PouchEX 2025 in Stockholm, Introduces Supply Chain Competency Model for the Nicotine Pouch Industry

Heno Biotech was invited to deliver a keynote address at PouchEX Stockholm 2025, presenting a new supply chain competency model for the nicotine pouch sector. The company showcased its end-to-end capabilities—from scientific research and advanced manufacturing to global regulatory compliance—underscoring the critical role of supply chain upgrading in driving sustainable industry growth.